Mannatech Inc. MTEX
Medicinal Chemicals and Botanical Products · data as of November 13, 2026
Mannatech Inc. (MTEX) is a healthcare company listed in the US with a market value of about $12M. In the twelve months to September 30, 2026 it had revenue of $103M and net income of -$425000, a net margin of -0.4%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is value (1/5); the weakest is future growth (0/5).
Key numbers: 5-year revenue growth of -7% a year, a 5-year average ROIC of 0%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 96% above the current price.
About Mannatech
Mannatech is listed in the US and classified in medicinal chemicals and botanical products. Revenue went from $190M in 2014 to $108M in 2025, a decline of about 5.0% a year. It was profitable in 4 of the last 10 years in our data. It spends 1% of revenue on research and development.
Score: 0.6 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- ROE above 15%
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $103M | $108M | $118M | $132M | $137M | $160M | $151M | $158M | $174M | $177M | $180M |
| Net income | -$425000 | -$15M | $2M | -$2M | -$4M | $10M | $6M | $3M | -$4M | -$2M | -$586000 |
| Free cash flow | -$648000 | -$4M | $2M | -$3M | -$4M | $10M | $5M | $4M | -$3M | $9M | -$2M |
| EPS (diluted) | $-0.31 | $-8.00 | $1.32 | $-1.20 | $-2.35 | $4.71 | $2.77 | $1.35 | $-1.53 | $-0.66 | $-0.22 |
| Net margin | -0.4% | -14.1% | 2.1% | -1.7% | -3.3% | 6.2% | 4.1% | 2.1% | -2.2% | -1.0% | -0.3% |
| ROIC | — | -23.2% | 6.6% | -5.1% | -1.6% | 23.5% | 10.2% | 13.0% | -0.3% | 4.9% | 1.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Mannatech stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 96% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Mannatech pay a dividend?
Not currently.
Is Mannatech a good stock to buy?
We do not give buy or sell advice. Mannatech scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.